INS and metabolic syndrome: It has been reported that TZDs, by their binding to PPAR gamma, modulate the transcription of genes of carbohydrates and lipid metabolism, improving insulin sensitivity, dyslipidemia, adipose tissue remodeling, and adiponectin synthesis [74,75].